Mimicking the addictive compound’s action in the brain could lead to new drugs for Alzheimer’s, Parkinson’s and schizophrenia
Mimicking the addictive compound’s action in the brain could lead to new drugs for Alzheimer’s, Parkinson’s and schizophrenia